RM

Raju Manjaly Rhee

Active Director Director DIN 06990147
DIN 06990147 First appointment Dec 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Dec 2014
Shareholding value •••• Premium profile

About Raju Manjaly Rhee

Data last updated:

Raju Manjaly Rhee is a Director at Amsperry Healthcare Private Limited (since 2024), Director at Doctek Innovation Private Limited (since 2023) and Director at Mayamd Technologies Private Limited (since 2021), and holds 1 more current directorship. The companies operate in Pharma, Healthcare and Business Services. The 3 current companies with reported revenue have a combined latest revenue of ₹1.06 Cr; the largest is Amsperry Healthcare Private Limited at ₹70.4 Lakh (FY 2025). Earlier, Raju Manjaly Rhee was a Director at Theacura Healthcare Consultancies Private Limited (2014–2017) and Director at Amsperry Private Limited (from 2023).

DIN 06990147
Primary Designation Director
Industry Pharma
First Appointment 15 Dec 2014
Oldest Company Age 5 yrs
Largest company Amsperry Healthcare Private Limited · ₹70.4 Lakh (FY 2025)
Combined revenue ₹1.06 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amsperry Healthcare Private Limited U46596KL2023PTC081929
Director10 Jan 20242023₹70.4 Lakh (FY 2025)Active
Doctek Innovation Private Limited U86201KA2023PTC171356
Director17 Mar 20232023₹18.2 Lakh (FY 2025)Active
Mayamd Technologies Private Limited U72502KL2021PTC069422
Director15 Jun 20212021₹17.2 Lakh (FY 2025)Active
Designated Partner03 Nov 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Dec 20142014Under Process Of Striking Off
Amsperry Private Limited U46596KL2023PTC084359
Director03 Nov 20232023Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Doctek Innovation Private Limited
Mayamd Technologies Private Limited
Amsperry Healthcare Private Limited
Amsperry Private Limited
Premium access

Shareholding and investment profile for Raju Manjaly Rhee

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raju Manjaly Rhee

Raju Manjaly Rhee currently holds 4 directorships: Amsperry Healthcare Private Limited (Director, since 10 Jan 2024, revenue ₹70.4 Lakh (FY 2025)); Doctek Innovation Private Limited (Director, since 17 Mar 2023, revenue ₹18.2 Lakh (FY 2025)); Mayamd Technologies Private Limited (Director, since 15 Jun 2021, revenue ₹17.2 Lakh (FY 2025)); Bioinnostellar Llp (Designated Partner, since 03 Nov 2023).

Raju Manjaly Rhee was first appointed on 15 Dec 2014 as Director at Theacura Healthcare Consultancies Private Limited. The most recent appointment on record is 10 Jan 2024 at Amsperry Healthcare Private Limited.

The 3 current companies of Raju Manjaly Rhee that report revenue have a combined latest revenue of ₹1.06 Cr: Amsperry Healthcare Private Limited ₹70.4 Lakh (FY 2025); Doctek Innovation Private Limited ₹18.2 Lakh (FY 2025); Mayamd Technologies Private Limited ₹17.2 Lakh (FY 2025).

Raju Manjaly Rhee held 2 earlier board appointments: Theacura Healthcare Consultancies Private Limited (Director, 15 Dec 2014 to 23 Mar 2017); Amsperry Private Limited (Director, from 03 Nov 2023).

The current boards of Raju Manjaly Rhee's companies include Manog Thrikkeparambil Soman Nair (Amsperry Healthcare Private Limited), Pavana George Alexi (Amsperry Healthcare Private Limited), Rajeev Krishnannair (Amsperry Healthcare Private Limited), Shahas Hassan (Amsperry Healthcare Private Limited), Shibu Chacko (Amsperry Healthcare Private Limited), Gunjan Lath (Doctek Innovation Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available